Larsen, Rick
U.S. Representative WA-2 Democratic PartyCongressional stock trade history disclosed under the STOCK Act, parsed and scored by FilingIQ.
Latest disclosed trades
Latest 10 of 88| Ticker | Type | Traded |
|---|---|---|
| PAYX | Sell | Apr 7, 2026 |
| NEE | Buy | Apr 7, 2026 |
| AWK | Sell | Apr 7, 2026 |
| AXP | Sell | Apr 7, 2026 |
| WAB | Buy | Apr 7, 2026 |
| BR | Sell | Apr 7, 2026 |
| CARR | Buy | Apr 7, 2026 |
| CASY | Buy | Apr 7, 2026 |
| SNDA | Sell | Apr 7, 2026 |
| — CNL Healthcare Properties Inc (w | Exchange | Mar 31, 2026 |
Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window, and to see the FilingIQ Score on every trade.
Larsen, Rick stock trade activity
FilingIQ has indexed 88 congressional stock trade disclosures for Larsen, Rick. The most recent disclosed transaction is dated Apr 7, 2026.
Across the full history, 42 purchases and 41 sales have been disclosed under the STOCK Act.
Top tickers traded by Larsen, Rick
Frequently asked
- How many stock trades has Larsen, Rick disclosed?
- FilingIQ tracks 88 Periodic Transaction Report disclosures for Larsen, Rick, with the most recent dated Apr 7, 2026. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
- Is Larsen, Rick a net buyer or net seller?
- Across the disclosed trade history, 42 (48%) were purchases and 41 (47%) were sales. Compensation and exchanges are filtered out of these counts.
- Where does FilingIQ's data on Larsen, Rick come from?
- Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.
Methodology & sources
Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.